Embolic microspheres are superior permanent or resorbable particulate embolic agents available in different well-calibrated size ranges for precise occlusion. And it may comprise additional functionality such as drug loading and elution capability, specific mechanical properties, imageability or radioactivity

The global Embolic Microspheres market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Embolic Microspheres volume and value at global level, regional level and company level. From a global perspective, this report represents overall Embolic Microspheres market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Nippon Kayaku
Boston Scientific
CeloNova BioSciences
BTG Corporate
Merit Medical Systems
ABK Biomedical
Terumo Corporation
BioSphere Medical
Tepha
Angio Dynamics
Jiangsu Hengrui Medicine

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Liquid
Solid

Segment by Application
Hospitals and Clinics
Research Institution